What Are the Benefits of CBD?
Interest in cannabidiol (CBD) has increased dramatically in recent years. Available in oils, lotions, and vaping fluid, the substance has been touted as a cure-all for various ailments including anxiety, arthritis, and insomnia. While its growing reputation is...
Five Things to Know About MDMA-Assisted Psychotherapy for PTSD
MDMA, the psychoactive drug sometimes known as ecstasy, is poised to become a powerful tool in the treatment of PTSD. In 2017, the U.S. Food and Drug Administration (FDA) designated MDMA-assisted psychotherapy as a breakthrough therapy. Although MDMA itself is not...
Confronting Addiction: Science, Policy, and Care
Luminaries in addiction research, policy, and clinical care, led by keynote speaker Nora Volkow, MD, Director of the National Institute on Drug Abuse (NIDA), participated in an all-day conference in the fall hosted by the Addiction Institute of...
Five Things to Know About Treating Patients with CBD
Yasmin Hurd, PhD, Director of the Addiction Institute of Mount Sinai (AIMS), has been at the forefront of cannabidiol (CBD) research for the past decade, particularly its effects on those struggling with addiction. In May 2019, she published study results from a...
New Intensive Program for Eating and Weight Disorders
In November, Mount Sinai’s Center of Excellence in Eating and Weight Disorders launched its new Intensive Program in an integrated clinical and research space at 53 East 96th Street. What began in 2002 as the Division of Eating and Weight Disorders has since grown...
Six Mount Sinai Researchers Awarded NARSAD Young Investigator Grants
The 2019 NARSAD Young Investigator grantees from the Brain and Behavior Research Foundation include six faculty members from the Icahn School of Medicine at Mount Sinai. Their research aims are listed below. Jessica Ables, MD, PhD, seeks to determine the effect of...